Bolton: Effective Use of Resources
The NHS belongs to us all. It is there to improve our health and well-being, support us to keep mentally and physically well, to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.
To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.
This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm. Carrying out operations that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere.
As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because
- There is only limited or no evidence of its effectiveness (whether it works or not).
- It is considered a low priority for funding, (for example, cosmetic surgery) compared to other treatments (for example, dementia or stroke care).
The Effective Use of Resources (EUR) Treatment Policies below lists those procedures that are not funded or where funding will only be made available if specific criteria are met. Work is also taking place across Greater Manchester to review the EUR policies contained within this list, as well as to develop new policies. This work will help to ensure that people across the whole of Greater Manchester are able to access these treatments in a fair and equitable manner.
It is important to remember that, while the NHS does not want to carry out operations which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a doctor, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the EUR process, where it will be decided if the NHS will carry out the operation. The EUR process will make decisions on an individual case by case basis. The EUR process for requesting funding on an individual patient basis is detailed in the Greater Manchester EUR Operational Policy below. This process is applied consistently by all Clinical Commissioning Groups in Greater Manchester. The Terms of Reference for our Individual Funding Request Panel can also be found below.
Contacts
General Practitioner (GP) - If you would like to discuss making an individual funding request (IFR), you should contact your General Practitioner, who may do this on your behalf.
Effective Use of Resources (EUR) Team for Greater Manchester
EUR process or funding applications: Tel: 0161 290 4901 / Email:
[email protected]
For complaints, Freedom of Information Requests (FOI) and Subject Access Requests (SAR) please see your local CCG’s website for details of their Patient Advice and Liaison Service (PALS).
Policies
Bolton CCG EUR Treatment Policies (includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list)
Greater Manchester EUR Operational Policy
Bolton CCG Individual Funding Request Panel – Terms of Reference
Bolton CCG Process Review Panel – Terms of Reference
Seeking Medical Treatment Abroad
As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS. Our EUR policies above also apply to treatment accessed in Europe. Further information regarding accessing medical treatment in Europe can be found on the NHS Choices website .
Treatments which are not the funding responsibility of CCGs in England
There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition. Further information regarding the treatments and conditions funded by NHS England can be found on their website .
Bury: Effective Use of Resources
The NHS belongs to us all. It is there to improve our health and well being, support us to keep mentally and physically well, to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.
To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.
This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm. Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere.
As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because:
- There is only limited or no evidence of its effectiveness (i.e. whether it works or not).
- It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).
The Effective Use of Resources (EUR) Treatment Policies below lists those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met. The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies. This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.
It is important to remember that while the NHS does not want to carry out treatments/procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure. The GM EUR process will make decisions on an individual case by case basis. The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below. This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM. The Terms of Reference for our Individual Funding Request Panel can also be found below.
Contacts
- PLEASE NOTE: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.
-
GM Effective Use of Resources (EUR) Team:
EUR process or funding requests: Tel: 0161 290 4901 / Email: [email protected]
EUR policy development: Tel: 0161 290 4937/4938 / Email: [email protected] - For complaints, Freedom of Information Requests (FOI) and Subject Access Requests (SAR) please see your local CCG’s website for details of their Patient Advice and Liaison Service (PALS).
Policies
- Bury CCG (North East Sector) EUR Treatment Policies (includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list. NOTE: GPs can find GM policies, local treatment policies, summary documents and funding request forms on their clinical systems)
- PbR Excluded Drugs List
- PbR Excluded Devices List
- Greater Manchester EUR Operational Policy
- Bury CCG Individual Funding Request Panel – Terms of Reference
- Bury CCG Process Review Panel – Terms of Reference
Seeking medical treatment abroad
As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS. Our EUR policies above also apply to treatment accessed in Europe. Further information regarding accessing medical treatment in Europe can be found on the NHS website .
Treatments which are not the funding responsibility of CCGs in England
There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition. Further information regarding the treatments and conditions funded by NHS England can be found on their website .
Manchester: Effective Use of Resources
The NHS belongs to us all. It is there to improve our health and well-being, support us to keep mentally and physically well, to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.
To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.
This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm. Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere.
As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because:
- There is only limited or no evidence of its effectiveness (i.e. whether it works or not).
- It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).
The Effective Use of Resources (EUR) Treatment Policies below lists those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met. The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies. This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.
It is important to remember that while the NHS does not want to carry out treatments/procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure. The GM EUR process will make decisions on an individual case by case basis. The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below. This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM. The Terms of Reference for our Individual Funding Request Panel can also be found below.
Contacts
PLEASE NOTE: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.
GM Effective Use of Resources (EUR) Team:
EUR process or funding requests: Tel: 0161 290 4901 / Email: [email protected]
EUR policy development: Tel: 0161 290 4937/4938 / Email: [email protected]
For complaints, Freedom of Information Requests (FOI) and Subject Access Requests (SAR) please see your local CCG’s website for details of their Patient Advice and Liaison Service (PALS).
Policies
- Manchester CCG EUR Treatment Policies
- PbR Excluded Drugs List
- PbR Excluded Devices List
- Greater Manchester EUR Operational Policy
- Manchester CCGs Individual Funding Request Panel and Process Review Panel – Terms of Reference
Seeking medical treatment abroad
As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS. Our EUR policies above also apply to treatment accessed in Europe. Further information regarding accessing medical treatment in Europe can be found on the NHS Choices website .
Treatments which are not the funding responsibility of CCGs in England
There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition. Further information regarding the treatments and conditions funded by NHS England can be found on their website .
Oldham: Effective Use of Resources
The NHS belongs to us all. It is there to improve our health and well-being, support us to keep mentally and physically well, to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.
To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.
This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm. Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere/
As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because:
- There is only limited or no evidence of its effectiveness (i.e. whether it works or not).
- It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).
The Effective Use of Resources (EUR) Treatment policies below list those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met.
The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies. This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.
It is important to remember that while the NHS does not want to carry out treatments/procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure. The GM EUR process will make decisions on an individual case by case basis. The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below. This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM. The Terms of Reference for our Individual Funding Request Panel can also be found below.
Contacts
PLEASE NOTE: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your care.
GM Effective Use of Resources (EUR) Team:
- EUR process or funding requests: Tel: 0161 290 4901 / Email: [email protected]
- EUR policy development: Tel: 0161 290 4937/4938 / Email: [email protected]
For complaints, Freedom of Information Requests (FOI) and Subject Access Requests (SAR) please see your local CCG’s website for details of their Patient Advice and Liaison Service (PALS).
Policies
- Oldham CCG (North East Sector) EUR Treatment Policies(includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list. NOTE: GPs can find GM policies, local treatment policies, summary documents and funding request forms on their clinical systems)
- PbR Excluded Drugs List
- PbR Excluded Devices List
- Greater Manchester EUR Operational Policy
- Oldham CCG Individual Funding Request Panel and Process Review Panel – Terms of Reference
Treatment abroad
As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS. Our EUR policies above also apply to treatment accessed in Europe. Further information regarding accessing medical treatment in Europe can be found on the NHS website.
Treatments which are not the funding responsibility of CCGs in England
There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition. Further information regarding the treatments and conditions funded by NHS England can be found on their website.
Heywood Middleton and Rochdale: Effective Use of Resources
The NHS belongs to us all. It is there to improve our health and well-being, support us to keep mentally and physically well, to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.
To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.
This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm. Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere.
As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because:
- There is only limited or no evidence of its effectiveness (whether it works or not).
- It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).
The Effective Use of Resources (EUR) Treatment Policies below lists those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met. The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies. This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.
It is important to remember that while the NHS does not want to carry out treatments/procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure. The GM EUR process will make decisions on an individual case by case basis. The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below. This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM. The Terms of Reference for our Individual Funding Request Panel can also be found below.
Contacts
Please note: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.
GM Effective Use of Resources (EUR) Team:
EUR process or funding requests: Tel: 0161 290 4901 / Email: [email protected]
EUR policy development: Tel: 0161 290 4937/4938 / Email: [email protected]
For complaints, Freedom of Information Requests (FOI) and Subject Access Requests (SAR) please see your local CCG’s website for details of their Patient Advice and Liaison Service (PALS).
Policies
- HMR CCG (North East Sector) EUR Treatment Policies (includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list. NOTE: GPs can find GM policies, local treatment policies, summary documents and funding request forms on their clinical systems)
- PbR Excluded Drugs List
- PbR Excluded Devices List
- Greater Manchester EUR Operational Policy
HMR CCG Individual Funding Request Panel and Process Review Panel – Terms of Reference
Seeking medical treatment abroad
As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS. Our EUR policies above also apply to treatment accessed in Europe. Further information regarding accessing medical treatment in Europe can be found on the NHS website .
Treatments which are not the funding responsibility of CCGs in England
There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition. Further information regarding the treatments and conditions funded by NHS England can be found on their website .
Salford: Effective Use of Resources
The NHS belongs to us all. It is there to improve our health and well-being, support us to keep mentally and physically well, to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.
To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.
This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm. Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere.
As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because:
- There is only limited or no evidence of its effectiveness (whether it works or not)
- It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care)
The Effective Use of Resources (EUR) Treatment Policies below lists those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met. The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies. This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.
It is important to remember that while the NHS does not want to carry out treatments/procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure.
The GM EUR process will make decisions on an individual case by case basis. The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below. This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM. The Terms of Reference for our Individual Funding Request Panel can also be found below.
Contacts
PLEASE NOTE: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.
GM Effective Use of Resources (EUR) Team:
EUR process or funding requests: Tel: 0161 290 4901 / Email: [email protected]
EUR policy development: Tel: 0161 290 4937/4938 / Email: [email protected]
For complaints, Freedom of Information Requests (FOI) and Subject Access Requests (SAR) please see your local CCG’s website for details of their Patient Advice and Liaison Service (PALS).
Policies
- Salford CCG EUR Treatment Policies (includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list. NOTE: GPs can find GM policies, local treatment policies, summary documents and funding request forms on their clinical systems)
- PbR Excluded Drugs List
- PbR Excluded Devices List
- Salford Greater Manchester EUR Operational Policy
- CCG Individual Funding Request Panel and Process Review Panel – Terms of Reference
Seeking Medical Treatment Abroad
As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS. Our EUR policies above also apply to treatment accessed in Europe. Further information regarding accessing medical treatment in Europe can be found on the NHS Choices website.
Treatments which are not the funding responsibility of CCGs in England
There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition. Further information regarding the treatments and conditions funded by NHS England can be found on their website.
Stockport: Effective Use of Resources
The NHS belongs to us all. It is there to improve our health and well-being, support us to keep mentally and physically well, to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.
To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.
This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm. Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere.
As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because:
- There is only limited or no evidence of its effectiveness (i.e. whether it works or not).
- It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).
The Effective Use of Resources (EUR) Treatment Policies below lists those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met. The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies. This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.
It is important to remember that while the NHS does not want to carry out treatments/procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure.
The GM EUR process will make decisions on an individual case by case basis. The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below. This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM. The Terms of Reference for our Individual Funding Request Panel can also be found below.
Contacts
PLEASE NOTE: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.
GM Effective Use of Resources (EUR) Team:
- EUR process or funding requests: Tel: 0161 290 4901 / Email: [email protected]
- EUR policy development: Tel: 0161 290 4937/4938 / Email: [email protected]
- For complaints, Freedom of Information Requests (FOI) and Subject Access Requests (SAR) please see your local CCG’s website for details of their Patient Advice and Liaison Service (PALS).
Policies
- Stockport CCG EUR Treatment Policies (includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list. NOTE: GPs can find GM policies, local treatment policies, summary documents and funding request forms on their clinical systems)
- PbR Excluded Drugs List
- PbR Excluded Devices List
- Greater Manchester EUR Operational Policy
- Stockport CCG Individual Funding Request Panel and Process Review Panel – Terms of Reference
Seeking Medical Treatment Abroad
As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS. Our EUR policies above also apply to treatment accessed in Europe. Further information regarding accessing medical treatment in Europe can be found on the NHS website .
Treatments which are not the funding responsibility of CCGs in England
There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition. Further information regarding the treatments and conditions funded by NHS England can be found on their website .
Tameside and Glossop: Effective Use of Resources
The NHS belongs to us all. It is there to improve our health and well-being, support us to keep mentally and physically well, to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives. To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.
This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm. Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere.
As happens in other parts of the country, we may decide that a treatment or proceduce should not be routinely funded because:
- There is only limited or no evidence of its effectiveness (i.e. whether it works or not).
- It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).
The Effective Use of Resources (EUR) Treatment Policies below lists those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met. The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies. This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.
It is important to remember that while the NHS does not want to carry out treatments/procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure. The GM EUR process will make decisions on an individual case by case basis. The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below. This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM. The Terms of Reference for our Individual Funding Request Panel can also be found below. PLEASE NOTE: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.
Contacts
PLEASE NOTE:The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.
GM Effective Use of Resources (EUR) Team:
- EUR process or funding requests: Tel: 0161 290 4901 / Email: [email protected]
- EUR policy development: Tel: 0161 290 4937/4938 / Email: [email protected]
- For complaints, Freedom of Information Requests (FOI) and Subject Access Requests (SAR) please see your local CCG’s website for details of their Patient Advice and Liaison Service (PALS).
Policies
NHS Tameside and Glossop CCG EUR Treatment Policies (includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list. NOTE: GPs can find GM policies, local treatment policies, summary documents and funding request forms on their clinical systems)
Greater Manchester EUR Operational Policy
Tameside & Glossop CCG Individual Funding Request Panel – Terms of Reference
Tameside & Glossop CCG Process Review Panel – Terms of Reference
Seeking medical treatment abroad
As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS. Our EUR policies above also apply to treatment accessed in Europe. Further information regarding accessing medical treatment in Europe can be found on the NHS website .
Treatments which are not the funding responsibility of CCGs in England
There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition. Further information regarding the treatments and conditions funded by NHS England can be found on their website .
Trafford: Effective Use of Resources
The NHS belongs to us all. It is there to improve our health and well-being, support us to keep mentally and physically well, to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.
To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.
This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm. Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere.
As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because:
- There is only limited or no evidence of its effectiveness (i.e. whether it works or not)
- It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).
The Effective Use of Resources (EUR) Treatment Policies below lists those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met. The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies. This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.
It is important to remember that while the NHS does not want to carry out treatments / procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure. The GM EUR process will make decisions on an individual case by case basis. The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below. This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM. The Terms of Reference for our Individual Funding Request Panel can also be found below.
Contacts
Please Note: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.
GM Effective Use of Resources (EUR) Team:
- EUR process or funding requests: Tel: 0161 290 4901 / Email: [email protected]
- EUR policy development: Tel: 0161 290 4937/4938 / Email: [email protected]
- For complaints, Freedom of Information Requests (FOI) and Subject Access Requests (SAR) please see your local CCG’s website for details of their Patient Advice and Liaison Service (PALS).
Policies
- Trafford CCG EUR Treatment Policies (includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list. Note : GPs can find GM policies, local treatment policies, summary documents and funding request forms on their clinical systems).
- PbR Excluded Drugs List
- PbR Excluded Devices List
- Greater Manchester EUR Operational Policy
- Trafford CCG Individual Funding Request Panel and Process Review Panel – Terms of Reference
Seeking medical treatment abroad
As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS. Our EUR policies above also apply to treatment accessed in Europe. Further information regarding accessing medical treatment in Europe can be found on the NHS Choices website.
Treatments which are not the funding responsibility of CCGs in England
There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition. Further information regarding the treatments and conditions funded by NHS England can be found on their website.
Wigan: Effective Use of Resources
The NHS belongs to us all. It is there to improve our health and well-being, support us to keep mentally and physically well, to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.
To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.
This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm. Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere.
As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because:
- There is only limited or no evidence of its effectiveness (i.e. whether it works or not).
- It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).
The Effective Use of Resources (EUR) Treatment Policies below lists those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met. The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies. This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.
It is important to remember that while the NHS does not want to carry out treatments/procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure. The GM EUR process will make decisions on an individual case by case basis. The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below. This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM. The Terms of Reference for our Individual Funding Request Panel can also be found below.
Contacts
PLEASE NOTE: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.
GM Effective Use of Resources (EUR) Team:
EUR process or funding requests: Tel: 0161 290 4901 / Email: [email protected]
EUR policy development: Tel: 0161 290 4937/4938 / Email: [email protected]
For complaints, Freedom of Information Requests (FOI) and Subject Access Requests (SAR) please see your local CCG’s website for details of their Patient Advice and Liaison Service (PALS).
Policies
- Wigan Borough CCG EUR Treatment Policies (includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list. NOTE: GPs can find GM policies, local treatment policies, summary documents and funding request forms on their clinical systems)
- PbR Excluded Drugs List
- PbR Excluded Devices List
- Greater Manchester EUR Operational Policy
- Wigan CCG Individual Funding Request Panel – Terms of Reference
- Wigan CCG Process Review Panel – Terms of Reference
Treatments which are not the funding responsibility of CCGs in England
There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition. Further information regarding the treatments and conditions funded by NHS England can be found on their website .
Seeking Medical Treatment Abroad
As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS. Our EUR policies above also apply to treatment accessed in Europe. Further information regarding accessing medical treatment in Europe can be found on the NHS Choices website .
Funding Requests
How does the IFR/IPA Application System work in practice?
GPs, service providers and clinical staff treating registered patients of any one of the GM CCGs are expected to implement EUR treatment policies.
Where there is a funding mechanism of Monitored Approval treatment may be undertaken in line with the agreed EUR policy criteria / routine commissioning arrangements. Funding approval is not required and the CCGs do not need to be notified of the planned treatment. When procedures are undertaken on the basis of meeting the criteria specified within the policy, this should be clearly documented within the clinical notes. Failure to do so will be considered by CCGs as lack of compliance. Audits may be undertaken to ensure adherence the agreed commissioning arrangements.
Where there is a funding mechanism of Individual Prior Approval the specific treatment falls outside of routinely commissioned arrangements and the CCGs have specifically requested that funding is sought for a particular treatment. The treatment must not be undertaken without funding approval.
Where there is a funding mechanism of Individual
Funding Request (exceptional case) approval a decision has
been taken not to commission that specific treatment. This means
treatment will only be funded if the application proves exceptional
clinical need and that is supported by the CCG. Please refer to the GM EUR Operational Policy for further guidance
on clinical exceptionality. Treatment must not be undertaken without
funding approval. This funding mechanism also applies when the patient
does not meet the specified clinical criteria.
Who can apply for funding?
These are clinician lead applications, where by the patients clinician or GP can submit a funding request for consideration.
Applications for funding should be submitted on the appropriate the treatment specific form where one is available. The use of the form is an attempt to ensure that applications are
- Appropriate
- Contain adequate information
- Address all relevant factors
Before requesting funding for a patient, please check the policy criteria and ensure that all the appropriate information is submitted; otherwise a decision will be made on the basis of the information provided. It is important, therefore, that the form is as fully completed as possible before submission. An incomplete form will, at best, delay the funding request process through additional information having to be sought and, at worst, may mean the request being turned down because all of the relevant details have not been presented.
PLEASE NOTE: It is the responsibility of the requesting clinician (together with the patient) to supply the information / evidence required to support the request – that the treatment requested is clinically and cost-effective and, where the case relates to exceptionality, that the patient’s case differs significantly from others with the same condition and stage of disease. Please refer to the GM EUR Operational Policy for further guidance on clinical exceptionality.
The EUR process should not be used where the intention is to introduce a new intervention for a definable group of patients (however small). You should forward such requests for consideration by the CCG commissioners, usually via the development of a business case for the CCG to consider as part of its annual commissioning round.
Instructions for completion of forms
- The application form should be completed electronically using MS
Word.
- When complete, save the document to your own file folders.
- Please ensure that any additional information that you wish to be
considered alongside the funding form is included as either
hyperlinks within the form or sent by e-mail as additional
documents.
- Clinical papers cited as references should be provided in full;
abstracts, hyperlinks to abstracts or hyperlinks to papers only
available by subscription to Journals are not acceptable.
- Please send the completed form to our secure NHSmail address:
[email protected]. Any documents that need to be submitted in support
of a request that are not in electronic format can be scanned and
emailed also. Please do not send any correspondence
via post.
If you would like further information regarding the EUR processes or advice on completing this form, please contact the Greater Manchester Effective Use of Resources (EUR) Team on: 0161 290 4901 Monday to Friday between 9am and 5pm.
Please click on the area below where
your GP practice is based for more information
on what interventions are not routinely commissioned or will only be routinely
commissioned or performed when specific criteria are met.
The Greater Manchester (GM) Effective Use of Resources (EUR) function provides Individual Funding Request (IFR) and Individual Prior Approval (IPA) management, along with the development GM EUR treatment policies.
Additional Links
Contacts
-
Funding Requests
Tel: 0161 290 4901
Email: [email protected] -
Policy Development
Tel: 0161 290 4937 or 4938
Email: [email protected]